Results 151 to 160 of about 3,429 (181)

Pertuzumab/trastuzumab/trastuzumab-emtansine

Reactions Weekly, 2020
openaire   +1 more source

Trastuzumab

Reactions Weekly, 2019
  +5 more sources

Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial

Lancet, The, 2023
JOSÉ Manuel Pérez-García, Sevilay Altintas, Roberto Hegg   +2 more
exaly  

Trastuzumab/trastuzumab emtansine

Reactions Weekly, 2017
openaire   +1 more source

Trastuzumab

Reactions Weekly, 2014
openaire   +2 more sources

Trastuzumab

Reactions Weekly, 2015
openaire   +2 more sources

Pertuzumab/trastuzumab/trastuzumab-emtansine

Reactions Weekly, 2018
openaire   +1 more source

Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors

Annals of Oncology, 2012
Josep Tabernero, Serena Di Cosimo, Maria Vidal Losada   +2 more
exaly  

Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer

Breast Cancer Research and Treatment, 2010
Teemu Junttila, Mark X Sliwkowski, Li Guangmin   +2 more
exaly  

Trastuzumab

Reactions Weekly, 2022
openaire   +1 more source